Literature DB >> 883821

Antimicrobial activity of several antibiotics and a sulfonamide against Chlamydia trachomatis organisms in cell culture.

C C Kuo, S P Wang, J T Grayston.   

Abstract

Minimum inhibitory concentrations of several antibiotics and a sulfonamide for growth of the 15 known immunotypes of Chlamydia trachomatis were determined in HeLa 229 cell cultures. The concentrations for complete inhibition of infectious-organism production were (per milliliter): tetracycline, 0.02 to 0.5 mug; rosamicin, 0.05 to 0.25 mug; erythromycin, 0.1 to 0.5 mug; chloramphenicol, 10 mug; penicillin, 0.02 to 50 U; ampicillin, 0.1 to 50 mug; and sulfisoxazole, 2 to 200 mug. The same concentrations of tetracycline, rosamicin, erythromycin, and chloramphenicol were sufficient to inhibit C. trachomatis inclusion formation. An increased concentration of sulfisoxazole was often needed to inhibit inclusion formation. Penicillin at 100 U/ml and ampicillin at 100 mug/ml failed to completely inhibit inclusion formation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 883821      PMCID: PMC352157          DOI: 10.1128/AAC.12.1.80

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Production and properties of a penicillinresistant strain of feline pneumonitis virus.

Authors:  J W MOULDER; B R McCORMACK; F M GOGOLAK; M M ZEBOVITZ; M K ITATANI
Journal:  J Infect Dis       Date:  1955 Jan-Feb       Impact factor: 5.226

2.  Susceptibility of a trachoma agent grown in FL cell cultures to antibiotics and a sulfa drug.

Authors:  H BERNKOPF; P MASHIAH; Y BECKER
Journal:  Proc Soc Exp Biol Med       Date:  1962-10

3.  Sensitivity of mouse pneumonitis organisms to ampicillin.

Authors:  A C ALLISON; D BUSBY
Journal:  Br Med J       Date:  1962-09-29

4.  Experimental chemotherapy of infection with agents of the psittacosis-lymphogranuloma-trachoma group.

Authors:  E W HURST
Journal:  Ann N Y Acad Sci       Date:  1962-03-05       Impact factor: 5.691

5.  Development of resistance to penicillin and to chlortetracycline in psittacosis virus.

Authors:  F B GORDON; V W ANDREW; J C WAGNER
Journal:  Virology       Date:  1957-08       Impact factor: 3.616

6.  Biological studies with rosamicin, a new Micromonospora-produced macrolide antibiotic.

Authors:  J A Waitz; C G Drube; E L Moss; M J Weinstein
Journal:  J Antibiot (Tokyo)       Date:  1972-11       Impact factor: 2.649

7.  Three new immunologic types of trachoma-inclusion conjunctivitis organisms.

Authors:  S P Wang; J T Grayston; J L Gale
Journal:  J Immunol       Date:  1973-03       Impact factor: 5.422

8.  TRIC type K, a new immunologic type of Chlamydia trachomatis.

Authors:  C C Kuo; S P Wang; J T Grayston; E R Alexander
Journal:  J Immunol       Date:  1974-08       Impact factor: 5.422

9.  Primary isolation of TRIC organisms in HeLa 229 cells treated with DEAE-dextran.

Authors:  C Kuo; S Wang; B B Wentworth; J T Grayston
Journal:  J Infect Dis       Date:  1972-06       Impact factor: 5.226

10.  Further classification of TRIC agents from ocular trachoma and other sources by the mouse toxicity prevention test.

Authors:  E R Alexander; S P Wang; J T Grayston
Journal:  Am J Ophthalmol       Date:  1967-05       Impact factor: 5.258

View more
  33 in total

1.  In vitro assays of the efficacy of antimicrobial agents in controlling Chlamydia trachomatis propagation.

Authors:  C K Lee; W R Bowie; E R Alexander
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

2.  N-acylated derivatives of sulfamethoxazole and sulfafurazole inhibit intracellular growth of Chlamydia trachomatis.

Authors:  Sania Marwaha; Hanna Uvell; Olli Salin; Anders E G Lindgren; Jim Silver; Mikael Elofsson; Asa Gylfe
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

Review 3.  Susceptibility testing of Chlamydia trachomatis: from eggs to monoclonal antibodies.

Authors:  J M Ehret; F N Judson
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

4.  Commercially available fluorescein-conjugated monoclonal antibody for determining the in vitro activity of antimicrobial agents against Chlamydia trachomatis.

Authors:  J M Webberley; R S Matthews; J M Andrews; R Wise
Journal:  Eur J Clin Microbiol       Date:  1987-10       Impact factor: 3.267

5.  In vitro drug susceptibility of Chlamydia sp. strain TWAR.

Authors:  C C Kuo; J T Grayston
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

6.  In vitro activity of clavulanic acid, amoxicillin, and ticarcillin against Chlamydia trachomatis.

Authors:  W R Bowie
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

7.  Comparison of the in vitro activities of ofloxacin and tetracycline against Chlamydia trachomatis as assessed by indirect immunofluorescence.

Authors:  J M Bailey; C Heppleston; S J Richmond
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

8.  Immediate cytotoxicity of Chlamydia trachomatis for mouse peritoneal macrophages.

Authors:  C C Kuo
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

9.  Relative resistance to erythromycin in Chlamydia trachomatis.

Authors:  A Mourad; R L Sweet; N Sugg; J Schachter
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

10.  In vitro and in vivo efficacy of antimicrobials against Chlamydia trachomatis.

Authors:  W R Bowie
Journal:  Infection       Date:  1982       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.